Arash Mostaghimi, MD, MPA, MPH, assistant professor of dermatology, director of the inpatient dermatology consult service, and codirector of the Complex Medical Dermatology Fellowship at Brigham & ...
Discover Equillium Inc.'s groundbreaking patent for a ?c cytokine antagonist peptide, offering new hope for treating alopecia and immune-mediated hair loss.
Nektar Therapeutics (Nasdaq: NKTR) today announced several presentations for rezpegaldesleukin (REZPEG) at the 2024 European Academy of Dermatology and Venereology (EADV) Congress. In addition to two ...
Small areas of scarring alopecia gradually appear and may become ... as relapse is common once treatment is stopped. Addition of topical mupirocin can help to improve outcome.